Implementing Oral Systemic Corticosteroids for Pediatric Asthma into EMS Treatment Guidelines: A Qualitative Study

Kayla McManus1, Alexandra Cheetham2, Lauren Riney2

  • 1Division of Pediatric Emergency Medicine, Department of Emergency Medicine, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA.

Prehospital Emergency Care
|September 20, 2022
PubMed

Insights

Oral corticosteroids (OCS) offer a viable alternative for pediatric asthma treatment by emergency medical services (EMS). Implementation barriers include clinician inexperience and knowledge gaps, while facilitators involve peer competition and pediatric medical director support.

Area of Science:

  • Pediatric Emergency Medicine
  • Implementation Science
  • Health Services Research

Background:

  • Respiratory distress is a common pediatric emergency, with asthma as the leading cause.
  • Early corticosteroid administration in the emergency department (ED) improves outcomes for pediatric asthma.
  • Emergency medical services (EMS) can facilitate earlier treatment, but intravenous (IV) access is challenging in children, making oral corticosteroids (OCS) a logical alternative.

Purpose of the Study:

  • To qualitatively explore the implementation and adoption of OCS for pediatric asthma by EMS clinicians.
  • To identify barriers and facilitators influencing OCS use in prehospital pediatric asthma care.

Main Methods:

  • Semi-structured interviews and focus groups were conducted with EMS clinicians from diverse EMS systems.
  • Transcripts were thematically coded and analyzed using the Consolidated Framework for Implementation Research (CFIR).
  • The study examined 31 CFIR constructs across domains including inner setting and characteristics of individuals.

Main Results:

  • Key barriers included clinician unfamiliarity with pediatric patients, dosing, and corticosteroid benefits.
  • Facilitators comprised inter-agency competition, presence of a pediatric medical director, and feedback from receiving EDs.
  • Implementation success was significantly influenced by EMS agency structure and individual clinician characteristics.

Conclusions:

  • Implementing OCS for pediatric asthma in EMS is influenced by agency and clinician factors.
  • Enhanced education on OCS benefits and pediatric-specific training for EMS clinicians is crucial for effective implementation.
  • Addressing identified barriers and leveraging facilitators can improve the uptake of this evidence-based intervention.

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
366
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
282
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
364
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
412
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
538